Skip to main content
# Title Department Research Year
261 Novel 2-Indolinone Based derivatives Targeting Cell Cycle Checkpoint’s Proteins as Potential Anticancer Agents Department of Medicinal Chemistry 2021
262 Silver Nanoparticle-Coated Ethyl Cellulose Inhibits Tumor Necrosis Factor-α of Breast Cancer Cells Department of Industrial Pharmacy 2021
263 The protein tyrosine phosphatase SHP-1 (PTPN-6) but not CD45 (PTPR-C) is essential for the ligand-mediated regulation of CD22 in BCR-ligated B cells Department of Pharmaceutical Organic Chemistry 2021
264 Novel Urea Linked Ciprofloxacin-Chalcone Hybrids having Antiproliferative Topoisomerases I/II Inhibitory Activities and Caspases-Mediated Apoptosis Department of Pharmaceutical Organic Chemistry 2021
265 Enhanced molecular imprinted electrochemical sensing of histamine based on signal reporting nanohybrid Department of Pharmaceutical Organic Chemistry 2021
266 Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo Department of Industrial Pharmacy 2021
267 Betaxolol‐loaded Niosomes Integrated Within pH‐sensitive in situ Forming
Gel for Management of Glaucoma
Department of Pharmaceutics 2021
268 A New Approach to Model Sporadic Alzheimer’s Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice Department of Pharmacology 2021
269 In Vitro Antimicrobial Activity of Medicinal Plant Extracts against Some Bacterial Pathogens Isolated from Raw and Processed Meat Department of Microbiology and Immunology 2021
270 Novel 1,5-diaryl pyrazole-3-carboxamides as selective COX-2/sEH inhibitors with analgesic, anti-inflammatory, and lower cardiotoxicity effects Department of Pharmaceutical Organic Chemistry 2021